These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12479325)

  • 21. The tolerance and pharmacokinetics of clinafloxacin (CI-960) in healthy subjects.
    Bron NJ; Dorr MB; Mant TG; Webb CL; Vassos AB
    J Antimicrob Chemother; 1996 Dec; 38(6):1023-9. PubMed ID: 9023649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of sparfloxacin in patients with renal impairment.
    Dorr MB; Johnson RD; Jensen B; Magner D; Marbury T; Talbot GH
    Clin Ther; 1999 Jul; 21(7):1202-15. PubMed ID: 10463518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses.
    Giguère S; Sweeney RW; Bélanger M
    Am J Vet Res; 1996 Jul; 57(7):1025-30. PubMed ID: 8807015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetic analysis of enrofloxacin and its active metabolite ciprofloxacin after intravenous injection to cats with reduced kidney function.
    Foster JD; Abouraya M; Papich MG; Muma NA
    J Vet Intern Med; 2023; 37(6):2230-2240. PubMed ID: 37728198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enrofloxacin treatment of long-tailed macaques with acute bacillary dysentery due to multiresistant Shigella flexneri IV.
    Line AS; Paul-Murphy J; Aucoin DP; Hirsh DC
    Lab Anim Sci; 1992 Jun; 42(3):240-4. PubMed ID: 1320152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of grepafloxacin.
    Efthymiopoulos C
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():35-43. PubMed ID: 9484872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg.
    Boothe DM; Boeckh A; Boothe HW; Wilkie S; Jones S
    Vet Ther; 2002; 3(4):409-19. PubMed ID: 12584678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics, pharmacodynamics and therapeutics of pradofloxacin in the dog and cat.
    Lees P
    J Vet Pharmacol Ther; 2013 Jun; 36(3):209-21. PubMed ID: 23406008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of long-term administration of an injectable enrofloxacin solution on physical and musculoskeletal variables in adult horses.
    Bertone AL; Tremaine WH; Macoris DG; Simmons EJ; Ewert KM; Herr LG; Weisbrode SE
    J Am Vet Med Assoc; 2000 Nov; 217(10):1514-21. PubMed ID: 11128543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Sucralfate on the Relative Bioavailability of Enrofloxacin and Ciprofloxacin in Healthy Fed Dogs.
    KuKanich K; KuKanich B; Guess S; Heinrich E
    J Vet Intern Med; 2016; 30(1):108-15. PubMed ID: 26651022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple route and dose pharmacokinetics of enrofloxacin in juvenile Atlantic salmon.
    Stoffregen DA; Wooster GA; Bustos PS; Bowser PR; Babish JG
    J Vet Pharmacol Ther; 1997 Apr; 20(2):111-23. PubMed ID: 9131537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacokinetics of baytril (enrofloxacin) in dogs].
    Küng K; Wanner M
    Schweiz Arch Tierheilkd; 1994; 136(10):329-34. PubMed ID: 7801085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative tolerability of the newer fluoroquinolone antibacterials.
    Ball P; Mandell L; Niki Y; Tillotson G
    Drug Saf; 1999 Nov; 21(5):407-21. PubMed ID: 10554054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elimination of Pasteurella pneumotropica from a contaminated mouse colony by oral administration of Enrofloxacin.
    Ueno Y; Shimizu R; Nozu R; Takahashi S; Yamamoto M; Sugiyama F; Takakura A; Itoh T; Yagami K
    Exp Anim; 2002 Jul; 51(4):401-5. PubMed ID: 12221935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs.
    Walker RD; Stein GE; Hauptman JG; MacDonald KH
    Am J Vet Res; 1992 Dec; 53(12):2315-9. PubMed ID: 1335707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety, tolerability and pharmacokinetics of the new long-acting quinolone DW-116 after single and multiple dosing in healthy subjects.
    Meyerhoff C; Dilger C; Yoon SJ; Chung YH; Lee DK; Lee CW; Ryu JM; Choi MS; Pabst G; Reh C
    J Antimicrob Chemother; 1998 Sep; 42(3):349-61. PubMed ID: 9786475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and residues of enrofloxacin in chickens.
    Anadón A; Martínez-Larrañaga MR; Díaz MJ; Bringas P; Martínez MA; Fernàndez-Cruz ML; Fernández MC; Fernández R
    Am J Vet Res; 1995 Apr; 56(4):501-6. PubMed ID: 7785830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.
    Mengozzi G; Intorre L; Bertini S; Soldani G
    Am J Vet Res; 1996 Jul; 57(7):1040-3. PubMed ID: 8807018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs.
    Anadón A; Martínez-Larrañaga MR; Díaz MJ; Fernández-Cruz ML; Martínez MA; Frejo MT; Martínez M; Iturbe J; Tafur M
    Am J Vet Res; 1999 Nov; 60(11):1377-82. PubMed ID: 10566812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum concentrations and pharmacokinetics of enrofloxacin after intravenous and intragastric administration to mares.
    Haines GR; Brown MP; Gronwall RR; Merritt KA
    Can J Vet Res; 2000 Jul; 64(3):171-7. PubMed ID: 10935883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.